HVAD flow waveform morphologies: theoretical foundation and implications for clinical practice
JD Rich, D Burkhoff - Asaio Journal, 2017 - journals.lww.com
Continuous-flow ventricular assist device (cfVAD) performance and patient hemodynamic
conditions are intimately interrelated and dynamic, changing frequently with alterations in …
conditions are intimately interrelated and dynamic, changing frequently with alterations in …
ISHLT consensus statement for the selection and management of pediatric and congenital heart disease patients on ventricular assist devices Endorsed by the …
A Lorts, J Conway, M Schweiger, I Adachi… - The Journal of Heart …, 2021 - jhltonline.org
Background Heart failure (HF) is a significant cause of mortality in children and therefore
there is interest in understanding the optimal way to support these children with Ventricular …
there is interest in understanding the optimal way to support these children with Ventricular …
Diagnosis and treatment algorithm for blood flow obstructions in patients with left ventricular assist device
AM Scandroglio, F Kaufmann, M Pieri… - Journal of the American …, 2016 - jacc.org
Background: Thrombosis is an uncommon, but severe complication of left ventricular assist
devices (LVADs). Objectives: This study analyzed experience with obstruction of blood flow …
devices (LVADs). Objectives: This study analyzed experience with obstruction of blood flow …
Increased thromboembolic events with dabigatran compared with vitamin K antagonism in left ventricular assist device patients: a randomized controlled pilot trial
M Andreas, R Moayedifar, G Wieselthaler… - Circulation: Heart …, 2017 - Am Heart Assoc
Background—Left ventricular assist device–supported patients are usually anticoagulated
with a combination of aspirin and vitamin K antagonists. Long-term vitamin K antagonist …
with a combination of aspirin and vitamin K antagonists. Long-term vitamin K antagonist …
The influence of left ventricular assist device inflow cannula position on thrombosis risk
M Ghodrati, A Maurer, T Schlöglhofer… - Artificial …, 2020 - Wiley Online Library
The use of left ventricular assist devices (LVADs) as a treatment method for heart failure
patients has been steadily increasing; however, pathological studies showed presence of …
patients has been steadily increasing; however, pathological studies showed presence of …
[HTML][HTML] Global best practices consensus: Long-term management of patients with hybrid centrifugal flow left ventricular assist device support
C Hayward, I Adachi, S Baudart, E Davis… - The Journal of Thoracic …, 2022 - Elsevier
Objectives Six months after withdrawal of the HeartWare HVAD System (HVAD; Medtronic)
from sale, approximately 4000 patients continue ongoing support with this device. In light of …
from sale, approximately 4000 patients continue ongoing support with this device. In light of …
Improved aftercare in LVAD patients: development and feasibility of a smartphone application as a first step for telemonitoring
T Schmidt, P Mewes, JD Hoffmann… - Artificial …, 2020 - Wiley Online Library
For the success of the treatment with a left ventricular assist device (LVAD), both adequate
self‐management by the patient and an optimum level of support from the implanting …
self‐management by the patient and an optimum level of support from the implanting …
Left ventricular assist device as destination therapy: a state of the science and art of long-term mechanical circulatory support
Abstract Purpose of Review The purpose of this review is to synthesize and summarize
recent developments in the care of patients with end-stage heart failure being managed with …
recent developments in the care of patients with end-stage heart failure being managed with …
Outflow graft obstruction in patients with the HM 3 LVAD: A percutaneous approach
Background The use of the HeartMate 3 (HM3) left ventricular assist device (LVAD) is
expanding. Despite being associated with lower rates of adverse events and increased …
expanding. Despite being associated with lower rates of adverse events and increased …
[HTML][HTML] Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched …
A Francica, A Loforte, M Attisani… - Transplant …, 2023 - frontierspartnerships.org
Despite the withdrawal of the HeartWare Ventricular Assist Device (HVAD), hundreds of
patients are still supported with this continuous-flow pump, and the long-term management …
patients are still supported with this continuous-flow pump, and the long-term management …